The developed vector provides an attractive option for further development to address unmet medical needs—limb ischemia, peripheral neuropathy and other diseases that can be relieved by effects of HGF and VEGF165 on vascular and neuronal trophic in impaired tissues. This evidence concerns the gene HGF and limb ischemia.